FIBROSIS, LIVER
Clinical trials for FIBROSIS, LIVER explained in plain language.
Never miss a new study
Get alerted when new FIBROSIS, LIVER trials appear
Sign up with your email to follow new studies for FIBROSIS, LIVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can text messages and coaching reverse early liver scarring?
Disease control OngoingThis study is testing whether a 6-month coaching program delivered via smartphone can help people with early liver disease. Participants are randomly assigned to either start the program immediately or wait 6 months. The program uses texts and support to help people improve their…
Matched conditions: FIBROSIS, LIVER
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Diabetes pill may halt deadly liver scarring in hepatitis b
Disease control OngoingThis study is testing if a common diabetes medication, empagliflozin, can prevent or slow the progression of liver scarring (fibrosis and cirrhosis) in people with chronic hepatitis B. The trial involves 106 patients who are already taking standard antiviral drugs but still have …
Matched conditions: FIBROSIS, LIVER
Phase: PHASE4 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Hidden liver risk in diabetes: quick scan seeks silent scarring
Knowledge-focused OngoingThis study aims to find out how common fatty liver disease and serious liver scarring are in adults with type 1 diabetes. Researchers will screen over 500 patients using a quick, non-invasive scan and blood tests. The goal is to identify patients at high risk who may need to see …
Matched conditions: FIBROSIS, LIVER
Sponsor: Joslin Diabetes Center • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC